| Dr Aaron R Florkowski, MD | |
|
21620 Midland Dr, Ste B, Shawnee, KS 66218-9064 | |
| (913) 787-6724 | |
| (913) 273-1210 |
| Full Name | Dr Aaron R Florkowski |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 21620 Midland Dr, Shawnee, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326013251 | NPI | - | NPPES |
| P00969725 | Other | KS | RR MEDICARE |
| 200366790B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2004017834 (Missouri) | Secondary |
| 207W00000X | Ophthalmology | 04 30820 (Kansas) | Primary |
| Entity Name | Sharper Vision, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104051655 PECOS PAC ID: 7012057698 Enrollment ID: O20091211000296 |
News Archive
Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.
Professors Xiangmin Xu and Rozanne Sandri-Goldin, in collaboration with Professors Bert Semler and Todd Holmes at the University of California, Irvine, School of Medicine, were awarded a three-year, $4.3 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative grant.
Businessman Bill Moss's determination to fight his untreatable muscle-wasting disease may have paid off. Four years ago, Mr Moss, a former Macquarie Bank Executive Director, established a charitable research foundation, FSHD Global, which partly funded the Italian researchers who made the breakthrough.
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
› Verified 5 days ago
| Entity Name | Ft Scott Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497362628 PECOS PAC ID: 2860806569 Enrollment ID: O20210120001796 |
News Archive
Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.
Professors Xiangmin Xu and Rozanne Sandri-Goldin, in collaboration with Professors Bert Semler and Todd Holmes at the University of California, Irvine, School of Medicine, were awarded a three-year, $4.3 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative grant.
Businessman Bill Moss's determination to fight his untreatable muscle-wasting disease may have paid off. Four years ago, Mr Moss, a former Macquarie Bank Executive Director, established a charitable research foundation, FSHD Global, which partly funded the Italian researchers who made the breakthrough.
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
› Verified 5 days ago
| Entity Name | Ft Scott Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1982211728 PECOS PAC ID: 2769893718 Enrollment ID: O20220128001353 |
News Archive
Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.
Professors Xiangmin Xu and Rozanne Sandri-Goldin, in collaboration with Professors Bert Semler and Todd Holmes at the University of California, Irvine, School of Medicine, were awarded a three-year, $4.3 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative grant.
Businessman Bill Moss's determination to fight his untreatable muscle-wasting disease may have paid off. Four years ago, Mr Moss, a former Macquarie Bank Executive Director, established a charitable research foundation, FSHD Global, which partly funded the Italian researchers who made the breakthrough.
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron R Florkowski, MD 11184 Antioch Rd, Suite 356, Overland Park, KS 66210-2420 Ph: (913) 787-6724 | Dr Aaron R Florkowski, MD 21620 Midland Dr, Ste B, Shawnee, KS 66218-9064 Ph: (913) 787-6724 |
News Archive
Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.
Professors Xiangmin Xu and Rozanne Sandri-Goldin, in collaboration with Professors Bert Semler and Todd Holmes at the University of California, Irvine, School of Medicine, were awarded a three-year, $4.3 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative grant.
Businessman Bill Moss's determination to fight his untreatable muscle-wasting disease may have paid off. Four years ago, Mr Moss, a former Macquarie Bank Executive Director, established a charitable research foundation, FSHD Global, which partly funded the Italian researchers who made the breakthrough.
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
› Verified 5 days ago
Dr. William Albert Pilchard, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 14629 W 49th Terrace, Shawnee, KS 66216 Phone: 913-825-0052 | |
Dr. Robert Wayne Thompson Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11005 W 60th St Ste 210, Shawnee, KS 66203 Phone: 913-631-7700 Fax: 913-631-8080 | |
Charles Richard Ford, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4742 Black Swan Drive, Shawnee, KS 66216 Phone: 913-268-0265 Fax: 913-768-8210 |